HealthWise KnowledgeBase
Sulfasalazine for Juvenile Idiopathic Arthritis
Why It Is Used
Sulfasalazine is considered a second-line treatment for JIA. Its use is reserved for children with JIA who do not respond to nonsteroidal anti-inflammatory drugs (Reference NSAIDs Opens New Window) or methotrexate. Children who are allergic to sulfa medicines or salicylates cannot use this medicine.
| By: | Reference Healthwise Staff | Last Revised: June 5, 2012 |
| Medical Review: | Reference Susan C. Kim, MD - Pediatrics
Reference John Pope, MD - Pediatrics |
|
© 1995-2011, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.
